DRIVE-AB: Driving Re-investment in R&D and Responsible Antibiotic Use (FP7 IMI)

Project: Research

Participants

Close

Joint applicant

  • Astellas Pharma Inc.
  • Astra Zeneca US
  • British Society for Antimicrobial Chemotherapy
  • Cubist Pharmaceuticals Inc
  • GlaxoSmithKline Research & Development Ltd
  • London School of Economics & Political Science
  • Pfizer Limited
  • Radboud University
  • SANOFI-AVENTIS
  • Universite De Geneve
  • University of Antwerp (Universiteit Antwerpen)
  • University of Tubingen
  • Uppsala University
  • Wageningen University
Close
StatusFinished
Effective start/end date1/10/1430/09/17

Funding

  • European Commission - Other: £483,035.51

View graph of relations